Sixty-one overweight and obese adults with dyslipidemia and insulin resistance were randomized to placebo , 2g/day extended-release nicotinic acid ( ERN ) , 4g/day prescription omega-3 fatty acid ethyl ester ( P-OM3 ) , or combination therapy for 16 weeks .